Document:

Exhibit
10.1

 

EXECUTION VERSION

 

TRANSACTION
SUPPORT AGREEMENT

 

This
Transaction Support Agreement (this “Agreement”), dated as of July 31, 2022, is made by and among Ingevity
Corporation, a Delaware corporation (“Buyer”), William H. Carr, an individual resident of Alabama (“Bill
Carr”), Jerry N. Carr, an individual resident of Florida (“Jerry Carr”), Leon M. Gross, III,
an individual resident of Alabama (“Lee Gross” and, together with Bill Carr and Jerry Carr, the “Equityholders”
and each, an “Equityholder”), Ozark Holdings, Inc., an Alabama corporation (“Seller”),
and each of the other entities set forth on Exhibit A that are signatories hereto (such entities, collectively, the “Excluded
Subsidiaries” and each, an “Excluded Subsidiary”), in connection with that certain Equity Purchase
Agreement, dated as of the date hereof (the “Purchase Agreement”), by and among Buyer, Seller, Ozark Materials,
LLC, an Alabama limited liability company (“Ozark Materials”), and Ozark Logistics, LLC, an Alabama limited
liability company (“Ozark Logistics” and, together with Ozark Materials, the “Companies”
and each, a “Company”). Seller, the Equityholders, and the Excluded Subsidiaries are referred to herein from
time to time collectively as the “Ozark Parties” and individually as an “Ozark Party.”
Buyer and the Ozark Parties are referred to herein from time to time collectively as the “Parties” and individually
as a “Party.” Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms
in the Purchase Agreement.

 

In
consideration for the benefits to be received, directly or indirectly, by the Ozark Parties as a result of the consummation of the transactions
contemplated by the Purchase Agreement, and, as an inducement to Buyer’s willingness to enter into the Purchase Agreement, the
Parties hereby agree as follows:

 

1.
Transaction Support. As a material inducement to Buyer to enter into the Purchase Agreement and to consummate the transactions
contemplated thereby and the other Transaction Documents (collectively, the “Transactions”), each Equityholder
hereby acknowledges and agrees that he (a) has executed and delivered contemporaneously with the execution and delivery of the Purchase
Agreement, the written consent attached hereto as Exhibit B approving the Transactions on behalf of Seller and on behalf of each
Company (in Seller’s capacity as the sole member of each Company), (b) will not withdraw or rescind such written consent and (c)
will take all reasonable actions to continue to approve and support the Transactions. Each Equityholder agrees that he will not transfer,
in whole or in part, any of his direct or indirect equity interests in Seller or the Companies prior to the Closing or the earlier termination
of the Purchase Agreement in accordance with the terms therein.

 

2.
Exclusivity. No Equityholder shall solicit, initiate, or encourage the submission of any proposal or offer from any Person relating
to the acquisition of a portion of or all or substantially all of the capital stock or other securities or assets of any Acquired Company
(including any acquisition structured as a merger, consolidation, or share exchange) (each, a “Company Transaction”).
Each Equityholder shall, and shall cause their respective Affiliates and representatives to, terminate any and all negotiations or discussions
with any third party regarding any proposal concerning any Company Transaction. Within three Business Days following the date hereof,
each Equityholder shall instruct any such third party to return or destroy all non-public information provided to such Person in connection
with such Person’s consideration of any Company Transaction in accordance with the confidentiality agreement entered into by such
Person for the benefit of the Company.

 

3.
Representations and Warranties of the Equityholders. Each Equityholder represents and warrants to Buyer that the statements contained
in this Section 3 are correct and complete as of the date of this Agreement and as of the Closing Date.

 

    	 

     

    

 

(a)
Such Equityholder has all requisite capacity and authority to execute and deliver this Agreement and each other Transaction Document
to which he is a party (if any) and to perform such Equityholder’s obligations hereunder and thereunder. This Agreement and each
other Transaction Document to which he is a party (if any) has been duly and validly executed by such Equityholder and, assuming the
due execution and delivery by the other Parties and the other parties thereto, constitutes a legal, valid and binding obligation of such
Equityholder, enforceable in accordance with its terms and conditions, except as such enforceability may be limited by (i) bankruptcy,
insolvency, reorganization, moratorium or other similar Laws affecting or relating to creditors’ rights generally, and (ii) the
exercise of judicial or administrative discretion in accordance with general equitable principles, particularly as to the availability
of injunctive relief and other equitable remedies.

 

(b)
Neither the execution and delivery of this Agreement or any other Transaction Document to which he is a party (if any), the performance
of such Equityholder’s obligations hereunder or thereunder, nor the consummation of the Transactions will (i) violate any Law to
which such Equityholder or any of such Equityholder’s assets, rights or properties is subject, (ii) conflict with, result in a
breach of, constitute a default under, result in the acceleration of, create in any Person any right under (including any right to accelerate,
terminate, novate, modify or cancel), require any notice under or result in the loss or cancellation of benefits or rights under (in
each case, with or without notice or lapse of time or both), any Contract to which such Equityholder is a party or by which such Equityholder
is bound or to which any of the Seller Interests (as defined below) or any of such Equityholder’s assets are subject, or (iii)
result in the imposition or creation of (A) a Lien upon or with respect to any of the Interests or the Seller Interests, or (B) a Lien
(other than any Permitted Lien) upon or with respect to any of such Equityholder’s assets (other than the Seller Interests).

 

(c)
No Equityholder is required to give any notice to, make any filing with, or obtain any Consent from any Governmental Entity or any other
Person in order to execute and deliver this Agreement or the other Transaction Documents to which he is a party (if any), perform such
Party’s covenants hereunder and thereunder, and consummate the Transactions.

 

(d)
There are no Actions pending, or threatened, against such Equityholder that would adversely affect or materially impair or delay such
Equityholder’s performance under this Agreement or the other Transaction Documents to which he is a party (if any), the consummation
of the Transactions, or that affect Seller’s title to the Interests or such Equityholder’s title to the Seller Interests.

 

(e)
Except as set forth in Section 4.5 of the Disclosure Schedule, such Equityholder has not engaged or retained, and such Equityholder has
no Liability to pay any fees or commissions to, any broker, finder or agent with respect to the consummation of the Transactions or in
connection with the negotiation thereof.

 

(f)
The Equityholders collectively hold of record and own beneficially all of the equity interests in Seller (the “Seller Interests”),
and have good and valid title to such Seller Interests, free and clear of any restrictions on transfer (other than restrictions on transfer
under the Securities Act and applicable state securities Laws), Taxes and Liens. No Equityholder is a party to any option, warrant, purchase
right, subscription right, conversion right, exchange right or other Contract or commitment that could require such Equityholder to sell,
transfer or otherwise dispose of, or purchase, repurchase or otherwise acquire, the Interests or the Seller Interests, and there is no
Contract, agreement or arrangement not yet fully performed which would result in the creation of any of the foregoing. No Equityholder
is a party to any equityholder agreement, voting agreement, voting trust, proxy or other agreement, arrangement, understanding or other
Contract with respect to the voting of the Interests or the Seller Interests. Seller owns, directly or indirectly, all of the outstanding
equity interests of each Excluded Subsidiary.

 

    	2

     

    

 

4.
Representations, Warranties and Covenants of the Excluded Subsidiaries. Each Excluded Subsidiary represents and warrants to Buyer
that the statements contained in this Section 4 are correct and complete as of the date of this Agreement and as of the Closing
Date.

 

(a)
Such Excluded Subsidiary is a limited liability company, duly organized, validly existing and in good standing under the Laws of the
State in which such Excluded Subsidiary was organized.

 

(b)
Such Excluded Subsidiary has all requisite limited liability company power, legal right and authority to execute and deliver this Agreement
and each other Transaction Document to which it is a party (if any) and to perform such Excluded Subsidiary’s obligations hereunder
and thereunder. This Agreement and each other Transaction Document to which such Excluded Subsidiary is a party (if any) has been duly
and validly executed by such Excluded Subsidiary and, assuming the due execution and delivery by the other Parties and other parties
thereto, constitutes legal, valid and binding obligations of such Excluded Subsidiary, enforceable in accordance with their respective
terms and conditions, except as such enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or other
similar Laws affecting or relating to creditors’ rights generally, and (ii) the exercise of judicial or administrative discretion
in accordance with general equitable principles, particularly as to the availability of injunctive relief and other equitable remedies.
All necessary limited liability company or other action has been taken by such Excluded Subsidiary to authorize the execution, delivery
and performance by such Excluded Subsidiary of this Agreement and each other Transaction Document to which such Excluded Subsidiary is
a party (if any).

 

(c)
Neither the execution and delivery of this Agreement or any other Transaction Document to which it is a party (if any), the performance
of such Excluded Subsidiary’s obligations hereunder or thereunder, nor the consummation of the Transactions will (i) violate any
Law to which such Excluded Subsidiary or any of such Excluded Subsidiary’s assets, rights or properties is subject, (ii) conflict
with, result in a breach of, constitute a default under, result in the acceleration of, create in any Person any right under (including
any right to accelerate, terminate, novate, modify or cancel), require any notice under or result in the loss or cancellation of benefits
or rights under (in each case, with or without notice or lapse of time or both), any (A) Contract to which such Excluded Subsidiary is
a party or by which it is bound or (B) any provision of the organizational documents of such Excluded Subsidiary, or (iii) result in
the imposition or creation of (A) a Lien upon or with respect to any of the Interests or the Seller Interests or (B) a Lien (other than
any Permitted Lien) upon or with respect to any of such Excluded Subsidiary’s assets.

 

(d)
No Excluded Subsidiary is required to give any notice to, make any filing with, or obtain any Consent from any Governmental Entity or
any other Person in order to execute and deliver this Agreement or the Transaction Documents to which it is a party (if any) perform
such Excluded Subsidiary’s covenants hereunder or thereunder, and consummate the Transactions.

 

(e)
There are no Actions pending, or threatened, against such Excluded Subsidiary that would adversely affect or materially impair or delay
such Excluded Subsidiary’s performance under this Agreement or the other Transaction Documents to which it is a party (if any),
the consummation of the Transactions.

 

(f)
No Excluded Subsidiary has engaged or retained, and no Excluded Subsidiary has any Liability to pay any fees or commissions to, any broker,
finder or agent with respect to the consummation of the Transactions or in connection with the negotiation thereof.

 

(g)
Each Excluded Subsidiary agrees to be bound by the obligations of such Excluded Subsidiary contained in Section 6.9 and Section 6.10
of the Purchase Agreement to the same extent as if such Excluded Subsidiary were a party to the Purchase Agreement.

 

    	3

     

    

 

5.
Restrictive Covenants. As an inducement to Buyer to execute and deliver the Purchase Agreement and the other Transaction Documents
and to consummate the Transactions, and to preserve the goodwill associated with the Business, from and after the Closing Date through
the fifth anniversary of the Closing Date, (X) the Seller and each Excluded Subsidiary will not, and will cause its respective Subsidiaries
not to, and (Y) each Equityholder will not, and will cause his respective Affiliates (including, for the purposes of this Section
5 only, the Seller, the Excluded Subsidiaries and their Subsidiaries, for so long as such Excluded Subsidiaries and such Subsidiaries
continue to be Affiliates of Seller) (collectively with the Persons included in clause (X), the “Non-Compete Parties”
and each, a “Non-Compete Party”) not to, without the prior written consent of Buyer, directly or indirectly:

 

(a)
be involved in, engage in or participate in, whether as employer, employee, consultant, independent contractor, agent or advisor of,
or partner or owner of stock, equity or other financial interest in, any Person (including advertising or otherwise endorsing the products
or services of, soliciting customers or otherwise serving as an intermediary for, or loaning money or rendering any other form of financial
assistance to, any such Person), business or product or service line that competes with the Business as the Business is conducted on
the date hereof or was conducted at any time during the 24-month period prior to the date hereof anywhere in the United States or any
other country in which any of Buyer, Buyer’s direct and indirect Subsidiaries (including, from and after the Closing, the Company)
and the respective successors and assigns of each of the foregoing (the “Buyer-Related Parties” and each, a
“Buyer-Related Party”) is engaged in business as of the date hereof or has been engaged in business at any
time during the 24-month period prior to the date hereof directly or indirectly (including through its dealers, distributors, agents
or representatives) (the “Territory”); provided, that a violation of this Section 5(a) will not
arise solely as a result of an investment by a Non-Compete Party in shares of stock or other interest of a Person or any of its direct
or indirect subsidiaries listed on a national securities exchange or quotation system or traded in the over-the-counter market if such
Non-Compete Party does not (i) directly or indirectly hold, beneficially or of record, in the aggregate more than a total of two percent
of all such shares of stock or other interest issued and outstanding and (ii) serve as an officer, director, manager, employee, agent,
or representative of, or consult to, such Person or any of its direct or indirect subsidiaries;

 

(b)
solicit, or attempt to solicit, any Person that is or has been a customer, client, supplier, vendor, distributor, licensor, licensee
or any other business relation of any Acquired Company or the Business at any time during the 24-month period prior to the date hereof
to purchase from any source other than such Acquired Company or the Business any product or service supplied or provided by any Acquired
Company or the Business as of the date hereof or at any time during the 24-month period prior to the date hereof, or to cease doing business
with, refuse to do business with or to adversely alter or limit its business relationship with any Acquired Company or the Business;

 

(c)
(i) solicit, induce or influence, or attempt to solicit, induce or influence, any employee of, or consultant to, any Acquired Company
to either leave his or her employment or engagement, as applicable, or materially and adversely change such employment or engagement
with such Acquired Company, other than solicitations through general advertising media not targeted specifically at employees of or consultants
to any Acquired Company or (ii) hire any individual who is, or at any time during the 12-month period prior to the date hereof has been,
an employee (including those who respond to general solicitations permitted by clause (i) preceding), consultant or worker of any Acquired
Company to provide services (as an employee, consultant, worker or otherwise) to any Person other than such Acquired Company; provided,
that this clause (ii) will not prohibit the hiring of any Person (x) whose employment with an Acquired Company has been terminated by
such Acquired Company at least six months prior to the date of hiring or (y) who has contacted such Non-Compete Party on his or her own
initiative, in the case of each of clauses (x) and (y) without any direct or indirect solicitation, inducement or influence by or on
the behalf of such Non-Compete Party as described in clause (i) hereof;

 

    	4

     

    

 

(d)
assist, advise, instruct, aid or encourage any other Person in carrying out, directly or indirectly, any activity that would be prohibited
by the provisions of this Section 5 if such activity were carried out by such Non-Compete Party, either directly or indirectly,
and in particular such Equityholder agrees that he will not, directly or indirectly, individually or together with any other Person,
induce any employee, consultant or worker of a Buyer-Related Party to carry out, directly or indirectly, any such competitive activity;

 

(e)
engage in any practice the purpose of which is to evade the provisions of this Section 5; or

 

(f)
make (or cause to be made) to any Person any statement that such Non- Compete Party knows to be, or that would reasonably be understood
to be, disparaging or derogatory or otherwise negative or false concerning any Buyer-Related Party, or any of its or their respective
officers, directors, employees, managers, consultants, partners, direct or indirect equityholders, members, Affiliates, owners or agents
(or any of its or their products or services);

 

provided,
that this Section 5 will not prohibit (x) the employment or engagement as a consultant of an Equityholder by any Buyer-Related
Party following the Closing and any actions taken by such Equityholder solely in the course of fulfilling his duties as an employee or
consultant of a Buyer-Related Party or (y) the ownership or operation of the business of the Excluded Subsidiaries, as such business
is conducted as of the date hereof (the “Excluded Business”). Recognizing the specialized nature of each of
the Business and the business of the Buyer-Related Parties, each Equityholder acknowledges and agrees that the duration, geographic scope
and activity restrictions of the covenants set forth in this Section 5 are reasonable.

 

6.
Indemnification. 

 

(a)
Except to the extent included in Indebtedness or Final Working Capital, each Equityholder will indemnify Buyer and each Acquired Company,
jointly and severally with Seller pursuant to this Agreement and the Purchase Agreement, from, and will defend them and hold Buyer and
each Acquired Company harmless against, any losses asserted by Buyer or any Acquired Company based upon, arising out of, with respect
to or by reason of (i) Fraud and (ii) all Pre-Closing Taxes.

 

(b)
Seller and each Excluded Subsidiary will indemnify Buyer and each Acquired Company from, and will defend and hold them harmless against,
(i) any losses asserted by Buyer or any Acquired Company against such Excluded Subsidiary within five years following the Closing based
upon, arising out of, with respect to or by reason of any Liability that is attributable to the ownership and operation of the Excluded
Business by such Excluded Subsidiary, and (ii) any losses asserted by Buyer or any Acquired Company based upon, arising out of, with
respect to or by reason of any indemnification obligations asserted against the Buyer or any Acquired Company pursuant to Section 7 of
the Striping TSA with respect to clause (d) and clause (e) of the definition of Excluded Liabilities (as defined therein).

 

(c)
In addition, if Seller or any Excluded Subsidiary fails to honor its obligations to indemnify Buyer or any Acquired Company under this
Agreement, then the Equityholders will be responsible for such obligations to the same extent as Seller or any such Excluded Subsidiary,
as applicable.

 

(d)
The Person making a claim under this Section 6 is referred to as the “Indemnified Party”, and the Person
against whom such claims are asserted under this Section 6 is referred to as the “Indemnifying Party”.

 

    	5

     

    

 

(e)
If any Indemnified Party receives notice of the assertion or commencement of any Action made or brought by any Person who is not a Party
or an Affiliate of a Party or a representative of the foregoing (a “Third-Party Claim”) against such Indemnified
Party with respect to which the Indemnifying Party is obligated to provide indemnification under this Agreement, the Indemnified Party
shall give the Indemnifying Party prompt written notice thereof, but in any event not later than fifteen Business Days after receipt
of such notice of such Third-Party Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying
Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason
of such failure or otherwise prejudices the rights of the Indemnifying Party to defend the applicable Third-Party Claim. Such notice
by the Indemnified Party shall describe the Third-Party Claim in reasonable detail, shall include copies of all material written evidence
thereof and shall indicate the estimated amount, if reasonably practicable, of the loss that has been or may be sustained by the Indemnified
Party. The Indemnifying Party shall have the right to participate in, or by giving written notice to the Indemnified Party, to assume
the defense of any Third-Party Claim at the Indemnifying Party’s expense and by the Indemnifying Party’s own counsel, and
the Indemnified Party shall cooperate in good faith in such defense; provided, that if Seller is the Indemnifying Party, such
Indemnifying Party shall not have the right to defend or direct the defense of any such Third-Party Claim that (i) is asserted directly
by or on behalf of a Person that is a supplier, customer or other material business relationship of the Acquired Companies or the Business,
(ii) seeks an injunction or other equitable relief against the Indemnified Party, or (iii) if adversely determined, would otherwise be
expected to have a material adverse impact on the Business or the operations of the Acquired Companies. In the event that the Indemnifying
Party assumes the defense of any Third-Party Claim, subject to Section 6(f), it shall have the right to take such action as it
deems necessary to avoid, dispute, defend, appeal or make counterclaims pertaining to any such Third-Party Claim in the name and on behalf
of the Indemnified Party. The Indemnified Party shall have the right to participate in the defense of any Third-Party Claim with counsel
selected by it, subject to the Indemnifying Party’s right to control the defense thereof. The fees and disbursements of such counsel
shall be at the sole expense of the Indemnified Party, provided, that if in the reasonable opinion of counsel to the Indemnified Party,
there exists a conflict of interest between the Indemnifying Party and the Indemnified Party that cannot be waived, the Indemnifying
Party shall be liable for the reasonable fees and expenses of counsel to the Indemnified Party in each jurisdiction for which the Indemnified
Party determines counsel is required. If the Indemnifying Party elects not to compromise or defend such Third-Party Claim, fails to notify
the Indemnified Party in writing of its election to defend as provided in this Agreement within thirty days of the receipt of such notice,
or fails to diligently defend such Third-Party Claim, the Indemnified Party may, subject to Section 6(f), pay, compromise or defend
such Third-Party Claim and seek indemnification for any and all losses based upon, arising from or relating to such Third-Party Claim.
The Parties shall cooperate with each other in all reasonable respects in connection with the defense of any Third-Party Claim, including
making available records relating to such Third-Party Claim and furnishing, without expense (other than reimbursement of actual out-of-pocket
expenses) to the defending party, management employees of the non-defending party as may be reasonably necessary for the preparation
of the defense of such Third-Party Claim.

 

(f)
Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not enter into settlement of any Third-Party Claim
without the prior written consent of the Indemnified Party, except as provided in this Section 6(f). If a firm offer is made to
settle a Third-Party Claim without leading to liability or the creation of a financial or other obligation on the part of the Indemnified
Party and provides, in customary form, for the unconditional release of each Indemnified Party from all liabilities and obligations in
connection with such Third-Party Claim and the Indemnifying Party desires to accept and agree to such offer, the Indemnifying Party shall
give written notice to that effect to the Indemnified Party. If the Indemnified Party fails to consent to such firm offer within ten
days after its receipt of such notice, the Indemnified Party may continue to contest or defend such Third-Party Claim and, in such event,
the maximum liability of the Indemnifying Party as to such Third-Party Claim shall not exceed the amount of such settlement offer. If
the Indemnified Party fails to consent to such firm offer and also fails to assume defense of such Third-Party Claim, the Indemnifying
Party may settle the Third-Party Claim upon the terms set forth in such firm offer to settle such Third-Party Claim. If the Indemnified
Party has assumed the defense pursuant to Section 6(f), it shall not agree to any settlement without the written consent of the
Indemnifying Party (which consent shall not be unreasonably withheld or delayed).

 

    	6

     

    

 

(g)
Any Action by an Indemnified Party on account of a loss which does not result from a Third-Party Claim (a “Direct Claim”)
shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof, but in any event not
later than thirty days after the Indemnified Party becomes aware of such Direct Claim. The failure to give such prompt written notice
shall not, however, relieve the Indemnifying Party of its indemnification obligations, unless such failure has a prejudicial effect on
the defenses or other rights available to the Indemnifying Party with respect to such Direct Claim. Such notice by the Indemnified Party
shall describe the Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate
the estimated amount, if reasonably practicable, of the loss that has been or may be sustained by the Indemnified Party. The Indemnifying
Party shall have thirty days after its receipt of such notice to respond in writing to such Direct Claim. The Indemnified Party shall
allow the Indemnifying Party and its professional advisors to investigate the matter or circumstance alleged to give rise to the Direct
Claim, and whether and to what extent any amount is payable in respect of the Direct Claim and the Indemnified Party shall assist the
Indemnifying Party’s investigation by giving such information and assistance (including access to the Indemnified Party’s
premises and personnel and the right to examine and copy any accounts, documents or records) as the Indemnifying Party or any of its
professional advisors may reasonably request. If the Indemnifying Party does not so respond within such thirty day period, the Indemnifying
Party shall be deemed to have rejected such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be
available to the Indemnified Party on the terms and subject to the provisions of this Agreement.

 

(h)
Notwithstanding any provision of this Agreement to the contrary, in the event of any conflict or overlap between the provisions of this
Section 6 and Section 6.2(g) of the Purchase Agreement, Section 6.2(g) of the Purchase Agreement shall control. In addition, if Seller
fails to assert its rights under Section 6.2(g) of the Purchase Agreement, then the Equityholders will be entitled to such rights to
the same extent as Seller.

 

7.
Release. Except for the obligations of Buyer arising under this Agreement or the Transaction Documents, each Equityholder, on
his own behalf and on behalf of his respective representatives, agents, trustees, beneficiaries, successors, assigns, heirs and Affiliates,
does hereby irrevocably, unconditionally, voluntarily, knowingly, fully, finally and completely forever release and discharge each of
Buyer, the Acquired Companies, and their respective parents, subsidiaries, divisions, Affiliates, successors, assigns and predecessors
and their present and former owners, stockholders, equityholders, representatives, successors, beneficiaries, heirs and assigns, individually
and collectively (the “Released Parties”), from, against and with respect to any and all actions, accounts,
causes of action, complaints, charges, covenants, contracts, agreements, liabilities, defenses, duties, executions, fees, injuries, interest,
judgments, penalties, promises, reimbursements, remedies, suits, sums of money, and torts, of whatever kind or character, whether in
law, equity or otherwise, direct or indirect, fixed or contingent, foreseeable or unforeseeable, liquidated or unliquidated, known or
unknown, matured or unmatured, absolute or contingent, determined or determinable, that such Equityholder, or his representatives, agents,
trustees, beneficiaries, successors, assigns, heirs and Affiliates, ever had or now has, or may hereafter have or acquire, against the
Released Parties that arise out of or in any way relate, directly or indirectly, to any matter, cause or thing, act or failure to act
whatsoever with respect to the Acquired Companies or any of their respective affairs occurring at any time on or prior to the Closing
Date, including the ownership, operation, business, affairs, management, prospects or financial condition of the Acquired Companies.

 

    	7

     

    

 

8.
General Provisions.

 

(a)
This Agreement shall not confer any rights or remedies upon any Person other than the Parties and their respective successors and permitted
assigns.

 

(b)
Each Party shall bear its own costs and expenses (including legal fees and expenses) incurred in connection with this Agreement; provided,
that the foregoing provision shall not apply with respect to any indemnifiable losses under this Agreement or the Purchase Agreement.

 

(c)
Notwithstanding anything to the contrary in this Agreement, (a) each Party recognizes and acknowledges that a breach by it of any covenants,
agreements or obligations contained in this Agreement shall cause the other Party to sustain irreparable harm for which it would not
have an adequate remedy at Law, and therefore in the event of any such breach the aggrieved Party shall, without the posting of bond
or other security (any requirement for which each Party hereby waives), be entitled to seek the remedy of specific performance of such
covenants, agreements and obligations, including injunctive and other equitable relief, in addition to any other remedy to which it might
be entitled; (b) a Party shall be entitled to seek an injunction or injunctions to prevent breaches of any covenants, agreements or obligations
contained in this Agreement; and (c) in the event that any Action is brought in equity to enforce such covenants or agreements, neither
Party shall allege, and each Party hereby waives the defense or counterclaim, that there is an adequate remedy at Law.

 

(d)
Section 10.2 (Entire Agreement), Section 10.3 (Succession and Assignment), Section 10.6 (Counterparts), Section 10.7 (Headings), Section
10.8 (Notices), provided that any such notice must be sent: (a) if to Buyer, to Buyer’s at the address or email address specified
for such communications to Buyer in the Purchase Agreement, or at such other address as Buyer shall have specified to the other parties
hereto in writing and (b) if to any Ozark Party, to Seller at the address or email address specified for such communications to Seller
in the Purchase Agreement, or at such other address as Seller shall have specified to the other Parties in writing (for the avoidance
of doubt, any notices, requests, demands, claims, waivers, consents, and other communications deliverable to an Ozark Party may be delivered
in accordance with the provisions of this Section 8 to Seller, which delivery will be deemed effective with respect to such Ozark
Party), Section 10.9 (Governing Law; Venue), Section 10.10 (Waiver of Jury Trial), Section 10.11 (Amendments and Waivers), Section 10.12
(Severability), Section 10.14 (Construction), Section 10.15 (Incorporation Exhibits and Schedules), and Section 10.17 (Electronic Delivery)
of the Purchase Agreement are each hereby incorporated herein by reference and shall apply as if fully set forth herein, mutatis mutandis.

 

*
* * * *

 

    	8

     

    

 

In
Witness Whereof, the Parties have caused this Agreement
to be duly executed as of the date first above written.

 

	 	Buyer:
	 	 
	 	Ingevity
    Corporation
	 	 
	 	By:	/s/
    John Fortson
	 	Name:	John
    Fortson
	 	Title:	President
    and Chief Executive Officer

 

[Signature Page to Transaction Support Agreement]

 

    	9

     

    

 

	 	Ozark
    Parties:
	 	 
	 	Ozark
    Holdings, Inc.
	 	 
	 	By:	/s/
    Leon M. Gross, III
	 	Name:	Leon
    M. Gross, III
	 	Title:	President
    and Secretary
	 	 
	 	/s/
    William H. Carr
	 	William
    H. Carr
	 	 
	 	/s/
    Jerry N. Carr
	 	Jerry
    N. Carr
	 	 
	 	/s/
    Leon M. Gross, III
	 	Leon
    M. Gross, III
	 	 
	 	Ozark
    Traffic Management, LLC
	 	 
	 	By:	/s/
    Leon M. Gross, III
	 	Name:	Leon
    M. Gross, III
	 	Title:	Manager
	 	 
	 	Ozark
    Distribution Services, LLC
	 	 
	 	By:	/s/
    Leon M. Gross, III
	 	Name:	Leon
    M. Gross, III
	 	Title:	Manager
	 	 
	 	Ozark
    Safety Services, LLC
	 	 
	 	By:	/s/
    Leon M. Gross, III
	 	Name:	Leon
    M. Gross, III
	 	Title:	Manager
	 	 
	 	Ozark
    HOLDINGS of Florida, LLC
	 	 
	 	By:	/s/
    Leon M. Gross, III
	 	Name:	Leon
    M. Gross, III
	 	Title:	Manager
	 	 
	 	Mobile
    holding company, LLC
	 	 
	 	By:	/s/
    Leon M. Gross, III
	 	Name:	Leon
    M. Gross, III
	 	Title:	Manager

 

[Signature
Page to Transaction Support Agreement]

 

    	10

     

    

 

Exhibit
A

 

Excluded
Subsidiaries

 

		1.	Ozark
                                            Traffic Management, LLC, an Alabama limited liability company
		2.	Ozark
                                            Distribution Services, LLC, a Louisiana limited liability company
		3.	Ozark
                                            Safety Services, LLC, an Alabama limited liability company
		4.	Ozark
                                            Holdings of Florida, LLC, an Alabama limited liability company
		5.	Mobile
                                            Holding Company, LLC, an Alabama limited liability company

 

[Exhibit
A to Transaction Support Agreement]aimd_ex42.htm

EXHIBIT 4.1
     
 COMMON STOCK PURCHASE WARRANT
  
 AINOS, INC.
    
 	 Warrant Shares: _______ 
	  
	   Initial Exercise Date: _______, 2022

   
 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ____, 20271 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ainos, Inc., a company incorporated under the laws of the State of Texas (the “Company”), up to ___ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.
  
 Section 1. Definitions.  In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section 1:
  
 “Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.
  
 “Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.
  
 “Board of Directors” means the board of directors of the Company.
  
 ___________________________________  
 1 Insert the date that is the five year anniversary of the Initial Exercise Date; provided, however, that is such date is not a Trading Day, insert the immediately following Trading Day.
  
 	 
	1
	

	 

  
 “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.
  
 “Commission” means the United States Securities and Exchange Commission.
  
 “Common Stock” means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.
  
 “Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
  
 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
  
  “Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.
  
 “Registration Statement” means the Company’s registration statement on Form S-1 (File No. 333- 264527).
  
  “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
  
 “Trading Day” means a day on which the Common Stock is traded on a Trading Market.
  
 “Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).
  
 “Transfer Agent” means American Stock Transfer & Trust Company, the current transfer agent of the Company, with a mailing address of 6201 15th Ave, Brooklyn, NY 11219, and any successor transfer agent of the Company.
  
 “Underwriting Agreement” means the underwriting agreement, dated as of ___, 2022 between the Company and Maxim Group LLC as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its terms.
  
 	 
	2
	

	 

   
 “VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.
  
 “Warrant Agency Agreement” means that certain warrant agency agreement, dated on or about the Initial Exercise Date, between the Company and the Warrant Agent.
  
 “Warrant Agent” means the Transfer Agent and any successor warrant agent of the Company.
  
 “Warrants” means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Registration Statement.
  
 Section 2. Exercise.
  
 a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.
  
 Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder’s right to elect to receive a Definitive Certificate (as defined in the Warrant Agency Agreement) pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply.
  
 	 
	3
	

	 

  
 b) Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $[_____2, subject to adjustment hereunder (the “Exercise Price”).
  
 c) Cashless Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing ((A-B)(X)) by (A), where:
  
 	  
	 (A) = 
	 as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

	  
	  
	  

	  
	 (B) = 
	 the Exercise Price of this Warrant, as adjusted hereunder; and

	  
	  
	  

	  
	 (X) = 
	 the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

	  
	  
	  

 If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c).
  
 d) Mechanics of Exercise.
  
 ______________________________ 
 1 Insert [__]% of the price of each share of common stock sold in the Offering.
  
 	 
	4
	

	 

  
 i. Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for purposes of Regulation SHO to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.
  
 ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.
  
 iii. Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by notifying the warrant agent or the company of such rescission at any time prior to the delivery of the Warrant Shares.
  
 iv. Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.
  
 	 
	5
	

	 

  
 v. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.
  
 vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.
  
 vii. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.
  
 e) Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.
   
 	 
	6
	

	 

  
 Section 3. CertainAdjustments.
  
 a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re‐classification.
  
 b) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).
  
 c) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). To the extent this Warrant has not been partially or completely exercised at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder has exercised this Warrant.
  
 	 
	7
	

	 

  
 d) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the total voting power of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or 50% or more of the total voting power of the outstanding shares of Common Stock, (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, if the Fundamental Transaction is not within the Company’s control, including not approved by the Company’s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction. “Black Scholes Value” means the value of this Warrant based on the Black and Scholes Option Pricing Model obtained from the “OV” function on Bloomberg, L.P. (“Bloomberg”) determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public announcement of such contemplated Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the Holder’s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.
  
 	 
	8
	

	 

  
 e) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
  
 f) Notice to Holder.
  
 i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
  
 ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.
  
 g) Voluntary Adjustment By Company. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.
  
 	 
	9
	

	 

  
 Section 4. Transfer of Warrant.
  
 a) Transferability. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company or Warrant Agent unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company or Warrant Agent within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company or Warrant Agent assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
  
 b) New Warrants. If this Warrant is not held in global form through DTC (or any successor depositary), this Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
  
 c) Warrant Register. The Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate (as defined in the Warrant Agency Agreement), the Company) shall register this Warrant, upon records to be maintained by the Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate, the Company) for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.
  
 Section 5. Miscellaneous.
  
 a) No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.
  
 b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.
  
 	 
	10
	

	 

  
 c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.
  
 d) Authorized Shares.
  
 The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).
  
 Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.
  
 Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.
  
 e) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
  
 	 
	11
	

	 

  
 f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.
  
 g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
  
 h) Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, or e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at 8880 Rio San Diego Drive, San Diego, CA 92108, Attention: Lawrence Lin, Executive Vice President of Operations, email address: lawrence@ainos.com, or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.
  
 i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.
  
 	 
	12
	

	 

  
 j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.
  
 k) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.
  
 l) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.
  
 m) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.
  
 n) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.
  
 o) Warrant Agency Agreement. If this Warrant is held in global form through DTC (or any successor depositary), this Warrant is issued subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling.
  
 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.
  
 	  
	 AINOS, INC.
	  

	  
	  
	  
	  

	  
	 By:
	  
	  

	  
	  
	 Name:
 Title:
	  

   
 	 
	13
	

	 

   
 Exhibit 4.2
 NOTICE OF EXERCISE
  
 To: AINOS, INC.
  
 (1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.
  
 (2) Payment shall take the form of (check applicable box):
  
 [ ] in lawful money of the United States; or
  
 [ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).
  
 (3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:
  
 _______________________________
  
 The Warrant Shares shall be delivered to the following DWAC Account Number:
  
 _______________________________
  
 _______________________________
  
 _______________________________
  
 [SIGNATURE OF HOLDER]
  
 Name of Investing Entity: ________________________________________________________________________
 Signature of Authorized Signatory of Investing Entity: _________________________________________________
 Name of Authorized Signatory: ___________________________________________________________________
 Title of Authorized Signatory: ____________________________________________________________________
 Date: ________________________________________________________________________________________
   
 	 
	14
	

	 

  
 ASSIGNMENT FORM
  
 (To assign the foregoing Warrant, execute this form and supply required information.  Do not use this form to purchase shares.)
  
 FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
  
 	 Name:
	 ______________________________________

	  
  
	 (Please Print)
  

	 Address:
	 ______________________________________

	  
  
 Phone Number:
  
 Email Address:                                                             
  
	 (Please Print)
  
 ______________________________________
  
 ______________________________________
  

	 Dated: _______________ __, ______
  
	  
  

	 Holder’s Signature:                                           
  
	  
  

	 Holder’s Address:                                             
	  

  
 	 
	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00347-of-00352.parquet"}]]